Inhibition of liver trans-sulphuration pathway by propargylglycine mimics gene expression changes found in the mammary gland of weaned lactating rats: role of glutathione.
In the lactating mammary gland, weaning produces mitochondrial cytochrome c release and nuclear DNA fragmentation, as determined by gel electrophoresis. This is followed by a significant decrease in lactation. Weaning for 2 h produces an early induction of the tumour suppressor/transcription factor p53, whereas the oncoprotein c-Jun and c-Jun N-terminal kinase are elevated after 24 h of weaning when compared with controls. The expression of p21(cip1) and p27(kip1), cyclin-dependent kinase inhibitors, was significantly higher in weaned rats when compared with control lactating rats. All the changes mentioned above also happen in the lactating mammary gland when propargylglycine, an inhibitor of the liver trans-sulphuration pathway, is administered. This effect is partially reversed by N -acetylcysteine administration. The administration of buthionine sulphoximine, an irreversible inhibitor of gamma-glutamylcysteine synthetase, to lactating rats produces a decrease in GSH levels and changes in protein concentrations and gene transcripts similar to those in rats with impaired trans-sulphuration pathway. These data suggest that the inter-tissue flux of GSH is an important mechanism of L-cysteine delivery to the lactating mammary gland and emphasize the importance of this physiological event in maintaining the gene expression required to sustain lactation.
Zaragozá
Rosa
R
Departamento de Bioquímica y Biología Molecular, Facultades de Medicina y Farmacia, Universidad de Valencia, Avda Blasco Ibañez 17, 46010 Valencia, Spain.
García
Concha
C
Rus
A Diana
AD
Pallardó
Federico V
FV
Barber
Teresa
T
Torres
Luis
L
Miralles
Vicente J
VJ
Viña
Juan R
JR
D000111:Acetylcysteine / Q000008:administration & dosage; D000480:Alkynes / Q000494:pharmacology*; D000818:Animals; D001483:Base Sequence; D019328:Buthionine Sulfoximine / Q000008:administration & dosage; D003542:Cystathionine gamma-Lyase / Q000378:metabolism; D017931:DNA Primers; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects*; D005978:Glutathione / Q000502:physiology*; D005998:Glycine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D007774:Lactation; D008099:Liver / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D008321:Mammary Glands, Animal / Q000201:enzymology / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013455:Sulfur / Q000378:metabolism*; D014886:Weaning; D005723:gamma-Glutamyltransferase / Q000378:metabolism
D000480:Alkynes; D017931:DNA Primers; D019328:Buthionine Sulfoximine; C009055:propargylglycine; D013455:Sulfur; D005723:gamma-Glutamyltransferase; D003542:Cystathionine gamma-Lyase; D005978:Glutathione; D005998:Glycine; D000111:Acetylcysteine